Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?

Canadian Journal of Anesthesia

Volumn 63, Issue 7, 2016, Pages 891-

  Hudson, Robert J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM;

ANESTHESIA INDUCTION; CANADA; HUMAN; LETTER; LUNG FUNCTION; MEDICAL LITERATURE; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR MONITORING; PATIENT SAFETY; PERIPHERAL NERVE STIMULATOR; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY FAILURE; NEUROMUSCULAR BLOCKING; PROCEDURES;

CANADA; HUMANS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR MONITORING; PRACTICE GUIDELINES AS TOPIC;

EID: 84964334020     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-016-0639-5     Document Type: Letter

References (3)

1. Merchant R, Chartrand D, Dain S, et al. Guidelines to the practice of anesthesia – revised edition 2016. Can J Anesth 2016; 63: 86-112.
2. Stoelting RK. Monitoring of neuromuscular blockade: what would you expect if you were the patient? APSF Newsletter 2016; 30: 45-7.
3. Capron F, Fortier LP, Racine S, Donati F. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography. Anesth Analg 2006; 102: 1578-84.